Drug makers gain on accelerated FDA approval for a cervical cancer treatment.

Pieris and Seagen have amended an ongoing collaboration which will have the latter give the former $13 million in an equity investment as the two work together to study a gastric cancer drug.

These stocks that fell this past week could be 'buy the dip' opportunities. Recent losers include Seagen, Penn National, Palantir, Canopy Growth, Pepsi and more.

Stock futures rise as Wall Street debates tame inflation data; Bumble IPO raises $2.15 billion; Disney and Pepsi report earnings; Tilray surges again as cannabis sector is targeted by Reddit crowd.

The worst-performing stocks in the Nasdaq on Wednesday included Moderna, Seattle Genetics, and Facebook, among others.

"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.

"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.